Breast Neoplasms
Conditions
Brief summary
The main objective of this study is to describe the evolution in quality of life (QLQ-C30) for patients receiving breast cancer care at 3, 6 and 12 months after a "remission" consultation.
Detailed description
The secondary objectives of this study are: A. to describe changes in body image (Image Body Scale Version F) at 3, 6 and 12 months after a "remission" consultation. B. to describe changes in psychological distress (visual analog scale) at 3, 6 and 12 months after a "remission" consultation. C. to assess the time of resumption of work (date of last chemotherapy - date of the actual resumption of work) after a "remission" consultation. D. to evaluate the acceptance rate for the "remission" consultation. E. to describe the modes of the observed management, their distribution and the characteristics of the patients according to different monitoring arrangements.
Interventions
OTHERRemission Consultation
At the end of adjuvant treatment (adjuvant chemotherapy and / or radiotherapy), the patient is seen by a referent oncologist and included in the study. A "Remission" consultation with a psychotherapist is then proposed and its purpose explained to the patient. The patient agrees or refuses take advantage of the "Remission" consultation; in case of refusal, the reasons are documented and further information is provided, thus giving the opportunity for the patient to benefit from further psychological counseling if desired. If approval is given, the patient will be scheduled for the "Remission" consultation (duration 1 hour) . The latter includes a first phase evaluating the mental state of the patient, and then a proposal of individualized care if necessary and according to several methods, depending on the choice of the patient.
Sponsors
Centre Hospitalier Universitaire de Nīmes
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* The patient is receiving care for localized breast cancer and finished her adjuvant treatment (chemotherapy, radiotherapy) * The patient has completed his/her adjuvant therapy in the last 6 months (chemotherapy, radiotherapy).
Exclusion criteria
* The patient is participating in another study * The patient is under judicial protection * It is impossible to correctly inform the patient * The patient has a metastatic form of the disease at diagnosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The EORTC QLQ-C30 questionnaire | Day 0 |
Secondary
| Measure | Time frame |
|---|---|
| Body Image Scale | Day 0 |
| Psychological distress (visual analog scale) | Day 0 |
| Work recovery time (date of last chemotherapy - date of the actual resumption of work) | Month 3 |
| Acceptance of remission consultation (yes/no) | Day 0 |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORLuc Duwig, MD
Centre Hospitalier Universitaire de Nîmes
Outcome results
None listed